China Pharma SG&A Expense (Quarterly) Analysis

China Pharma Holding Inc (CPHI)

0.2951 -0.05 (-14.46%) USD | OTCM | May 28, 11:44

SG&A Expense (Quarterly) Chart

Historical SG&A Expense (Quarterly) Data

View and export this data back to 2001. Upgrade now.

Date	Value
March 31, 2024	0.5966M
December 31, 2023	0.9493M
September 30, 2023	0.4528M
June 30, 2023	0.2819M
March 31, 2023	0.5624M
December 31, 2022	1.194M
September 30, 2022	0.536M
June 30, 2022	0.5395M
March 31, 2022	0.6937M
December 31, 2021	1.147M
September 30, 2021	0.4363M
June 30, 2021	0.7752M
March 31, 2021	0.7873M
December 31, 2020	1.329M
September 30, 2020	0.9447M
June 30, 2020	1.050M
March 31, 2020	0.7147M
December 31, 2019	1.947M
September 30, 2019	0.9469M
June 30, 2019	0.8404M
March 31, 2019	0.9075M
December 31, 2018	1.674M
September 30, 2018	1.253M
June 30, 2018	1.069M
March 31, 2018	1.170M

Date	Value
December 31, 2017	1.895M
September 30, 2017	1.036M
June 30, 2017	1.415M
March 31, 2017	1.134M
December 31, 2016	2.155M
September 30, 2016	1.222M
June 30, 2016	1.639M
March 31, 2016	1.287M
December 31, 2015	1.719M
September 30, 2015	1.540M
June 30, 2015	1.472M
March 31, 2015	1.461M
December 31, 2014	1.64M
September 30, 2014	1.169M
June 30, 2014	1.010M
March 31, 2014	1.244M
December 31, 2013	1.717M
September 30, 2013	1.294M
June 30, 2013	1.293M
March 31, 2013	1.385M
December 31, 2012	1.690M
September 30, 2012	1.454M
June 30, 2012	1.695M
March 31, 2012	1.570M
December 31, 2011	2.220M

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (Quarterly) Range, Past 5 Years

0.2819M

Minimum

Jun 2023

1.947M

Maximum

Dec 2019

0.8362M

Average

0.7813M

Median

SG&A Expense (Quarterly) Benchmarks